Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920110190020201
Biomolecules & Therapeutics
2011 Volume.19 No. 2 p.201 ~ p.205
A Comparative Study of the Anti-Platelet Effects of cis- and trans-Resveratrol
Kim Hwa

Oh Seok-Jeong
Liu Yingqiu
Lee Moo-Yeol
Abstract
Although various biological activities of resveratrol have been extensively studied, most reports have focused on trans-resveratrol and little attention has been paid to the cis-isomer. In this study, the effect of cis-resveratrol on platelet activity was examined and compared with that of the trans-isomer. Treatment with cis-resveratrol resulted in inhibition of platelet aggregation induced by thrombin, collagen or ADP, which are representative aggregation-inducing agents, and the trans-isomer elicited the same effects. These effects were concentration-dependent in the range of 1-100 ¥ìM. However, the potency of the cis-isomer was much lower than that of the trans-isomer; the IC50 values for the cis-isomer versus the trans-isomer were 31 ¡¾ 12 vs 15 ¡¾ 3, 16 ¡¾ 3 vs 9 ¡¾ 4, and 60 ¡¾ 15 vs 25 ¡¾ 6 ¥ìM for thrombin-, collagen- and ADP-induced aggregation, respectively. These results indicate that cisresveratrol has a less potent anti-platelet activity, compared with the trans-isomer, and raise the possibility that the biological activities of the cis-isomer may be different from those of the trans-isomer. It will be necessary to evaluate the activity of cis-resveratrol independently of the trans-isomer.
KEYWORD
Resveratrol, Platelets, Anti-platelet effect
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed